|
Partnering with Consumers and Consumer PlansPartnering with Consumers and Consumer Plans The Sydney Local Health District is committed to working with consumers to improve healthcare services together. This is further supported by the following frameworks and strategic plans:
Consumer Engagement Plan The Sydney Local Health District Research Ethics & Governance Office requires investigators to take steps towards involving consumer involvement in clinical trial or research planning, and to demonstrate this has occurred through a range of documentation evidence such as team meeting notes, planning days, or advisory panel meeting meetings. Details of the consumer engagement plan should be added to the Protocol, please refer to our preferred Protocol templates. Alternatively, please complete the SLHD Consumer Engagement Plan. The Consumer Engagement Plan Progress Report can be used to provide an update on the progress of engaging with consumers throughout the study. Consumer Engagement Plan Consumer Engagement Plan. The Committee and the Research Ethics & Governance Office will review progress of the plan upon review of the study's final progress report and/or when an ethics extension amendment has been submitted if the study is continuing after ethics approval has expired. SLHD staff members can find additional resources on the SLHD Research Intranet page and are invited to attend the monthly Clinical Trials Drop-in Clinic, Ethics Drop-in Clinic or Governance Drop-in Clinic to seek further advice or assistance. Clinical Trials Specific Patient Reported Experience Measures (PREMs): To ensure clinical trial participants have the opportunity to provide direct, comprehensive and timely feedback about their experiences specific to clinical trials, a Clinical Trial PREMs questionnaire has been developed by the SLHD Research Support team. Effective 17 September 2024, all clinical trials studies conducted in the SLHD will now require a new statement, and a QR Code, to be added to the local Participant Information Statement prior to authorisation. Refer here for further information and instructions on how to include the PREMs survey in the documents. Trial participants who wish to provide additional feedback about their clinical trial or about any member of the clinical trials team will be encouraged to email SLHD-ResearchFeedback@health.nsw.gov.au. Such correspondences will be followed up by a member of the Research Governance team for appropriate escalation and resolution of any concerns identified. This feedback will provide useful data to comply with the requirements of the National Clinical Trials Governance Framework (NCTGF). Resources to assist researchers can be found below.
Resources: ACTA Consumer Involvement & Engagement Toolkit NHMRC Statement on Consumer Involvement Research Additional Tools, Resources and Recordings Consumers Health Forum of Australia
|

